Top Story

AAO airs concerns about beyond-use dates for repackaged Avastin

May 28, 2015

The American Academy of Ophthalmology has provided comments to the FDA expressing its concern that beyond-use dates for repackaged Avastin may limit the drug’s availability for the treatment of age-related macular degeneration.

The beyond-use dates (BUDs) were included in one of five draft guidance documents issued by the FDA in February to clarify provisions of the Drug Quality and Security Act and Compounding Quality Act. The laws were passed in 2013 in the wake of infectious outbreaks traced to steroids and repackaged Avastin provided at compounding pharmacies.

In the Journals

Light level largest contributor to visual acuity reduction

May 28, 2015
Mesopic visual acuity testing should utilize a standardized light level of 0.75 cd/m2, according to a study recently published in Optometry and Vision Science. Lin…
In the Journals

Pharmacist-managed medication refill clinics ease physician workload

May 28, 2015
Establishing a pharmacist-managed medication refill clinic decreased workloads for physicians, and improved refill-request processing time and patient care, according to…
Business News

Iridex reports revenues of $10.8 million in first quarter

May 28, 2015
Iridex reported $10.8 million in revenues in the first quarter 2015, a 5% increase from $10.3 million in the first quarter 2014, according to a press release.Net income…
In the Journals

Choroidal thickness decreases with age, greater axial length

May 28, 2015
Subfoveal choroidal thickness decreased significantly with age and increased axial length in a group of healthy eyes, according to a study.Investigators evaluated 155…
More News Headlines »
Agustin Gonzalez

BLOG: Keep your enemies close

April 28, 2015
Agustin L. Gonzalez, OD, FAAO, reminds us of the adage: “Keep your friends close, but your enemies…
More »